GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrthoPediatrics Corp (NAS:KIDS) » Definitions » 14-Day RSI

KIDS (OrthoPediatrics) 14-Day RSI : 38.95 (As of Dec. 12, 2024)


View and export this data going back to 2017. Start your Free Trial

What is OrthoPediatrics 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-12-12), OrthoPediatrics's 14-Day RSI is 38.95.

The industry rank for OrthoPediatrics's 14-Day RSI or its related term are showing as below:

KIDS's 14-Day RSI is ranked better than
82.56% of 883 companies
in the Medical Devices & Instruments industry
Industry Median: 49.11 vs KIDS: 38.95

Competitive Comparison of OrthoPediatrics's 14-Day RSI

For the Medical Devices subindustry, OrthoPediatrics's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrthoPediatrics's 14-Day RSI Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrthoPediatrics's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where OrthoPediatrics's 14-Day RSI falls into.



OrthoPediatrics  (NAS:KIDS) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OrthoPediatrics  (NAS:KIDS) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


OrthoPediatrics 14-Day RSI Related Terms

Thank you for viewing the detailed overview of OrthoPediatrics's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


OrthoPediatrics Business Description

Traded in Other Exchanges
Address
2850 Frontier Drive, Warsaw, IN, USA, 46582
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
Executives
Daniel J Gerritzen officer: General Counsel and Secretary 2850 FRONTIER DRIVE, WARSAW IN 46582
Mark C Throdahl director, officer: President and CEO ORTHOPEDIATRICS, 2850 FRONTER DR., WARSAW IN 46582
Fred Hite director, officer: Chief Financial Officer ORTHOPEDIATRICS, 2850 FRONTIER DR., WARSAW IN 46582
David R Bailey officer: Executive Vice President 2850 FRONTIER DRIVE, WARSAW IN 46582
Gregory A Odle officer: Executive Vice President 2850 FRONTIER DRIVE, WARSAW IN 46582
Joseph W Hauser officer: Sr VP & GM Trauma & Deformity 6428 RIDGELINE DR, HUDSON OH 44236
Terry D Schlotterback director 2850 FRONTIER DRIVE, WARSAW IN 46582
Dyer George Sinclair Mitchell director 55 ORCHARD ST., CAMBRIDGE MA 02140
Jimmy Duane Mcdonald director 28662 N. 71ST STREET, SCOTTSDALE AZ 85226
David R Pelizzon director, 10 percent owner 2850 FRONTIER DR, WARSAW IN 46582
Squadron Capital Holdings Llc 10 percent owner 18 HARTFORD AVENUE, PO BOX 223, GRANBY CT 06053
Squadron Capital Llc 10 percent owner 2850 FRONTIER DR., WARSAW IN 46582
Harold Ruf director 2850 FRONTIER DR, WARSAW IN 46582
Jennifer N. Pritzker 10 percent owner C/O SQUADRON CAPITAL LLC, 104 S. MICHIGAN AVENUE, SUITE 500, CHICAGO IL 60603
Infante (reynolds) Marie C director 2850 FRONTIER DR, WARSAW IN 46582